B-cell Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2016-06-03
  Clinical Trial Update: Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia [Phase 1]

  This notice reports the termination of a Phase 1 clinical trial studying monoclonal antibody 216 in combination with chemotherapy for childr…

• CLINICAL_TRIALS trial_result · 2016-05-18
  Clinical Trial Update: Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia

  This completed clinical trial from the Children's Oncology Group studied biomarkers as a diagnostic tool in samples from younger patients wi…

• CLINICAL_TRIALS trial_result · 2016-05-18
  Clinical Trial Update: Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia

  Completed clinical trial update studying gene analyses in samples from younger patients with relapsed childhood acute lymphoblastic leukemia…

• CLINICAL_TRIALS trial_result · 2016-05-11
  Clinical Trial Update: Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate

  This clinical trial update summarizes how young patients with acute lymphoblastic leukemia responded to or developed resistance to methotrex…

• CLINICAL_TRIALS trial_result · 2015-07-10
  Clinical Trial Update: Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma [Phase 1]

  This Phase 1 study evaluated a multi-drug regimen of temsirolimus, dexamethasone, mitoxantrone, vincristine, and pegaspargase in pediatric p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-02-12
  Clinical Trial Update: Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) [Phase 2]

  A confirmatory Phase II study evaluating blinatumomab (MT103) in patients with minimal residual disease in B-cell acute lymphoblastic leukem…

• CLINICAL_TRIALS trial_result · 2015-01-07
  Clinical Trial Update: Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) [Phase 2]

  Phase 2 study evaluating blinatumomab in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-ALL).

• CLINICAL_TRIALS trial_result · 2014-09-16
  Clinical Trial Update: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating chemotherapy plus rituximab for adults with Burkitt lymphoma or B-cell acute lymphoblastic leukemia has completed.

• CLINICAL_TRIALS trial_result · 2013-10-08
  Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 trial evaluating combination chemotherapy with rituximab in children with recurrent or refractory B-cell non-Hodgkin lymphoma or acu…

• CLINICAL_TRIALS trial_result · 2012-01-20
  Clinical Trial Update: Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

  Forodesine Hydrochloride (BCX-1777) was evaluated in a Phase 1/2 clinical trial for B-cell acute lymphoblastic leukemia. The study status is…